Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ayres

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Legal Medicine|January 5, 2002
Analysis of disputed single-parent/child and sibling relationships using 16 STR lociJ A Thomson, K L Ayres, V Pilotti, et al.
Oncotarget|May 11, 2019
PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cellsFabiola Cervantes-Gomez, Christine M Stellrecht, Mary L Ayres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 25, 2015
Dose Optimization of the Administered Activity in Pediatric Bone Scintigraphy: Validation of the North American Consensus GuidelinesKaren L Ayres, Stephanie E Spottswood, Dominique Delbeke, et al.
Blood|May 6, 2010
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cellsKumudha Balakrishnan, Jan A Burger, Maite P Quiroga, et al.
Biochemical Pharmacology|May 30, 2009
Inhibition of ATP synthase by chlorinated adenosine analogueLisa S Chen, Billie J Nowak, Mary L Ayres, et al.
Frontiers in Oncology|May 25, 2023
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemiaNatalia Timofeeva, Mary L Ayres, Natalia Baran, et al.
Blood|April 22, 2014
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cellsAmal A El-Mabhouh, Mary L Ayres, Elizabeth J Shpall, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1985
[Immunologic parameters and HLA groups in 50 Portuguese families with insulin-dependent diabetes. Clinical and laboratory correlation]M Cruz, L G Correia, J Nunes Corrêa, et al.
Oncotarget|June 5, 2018
Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cellsHima V Vangapandu, Brandon Alston, Joshua Morse, et al.
Blood Cancer Journal|December 18, 2024
Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton's tyrosine kinase expression levelsGorkem Kismali, Ganiraju Manyam, Nitin Jain, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Legal Medicine|January 5, 2002
Analysis of disputed single-parent/child and sibling relationships using 16 STR lociJ A Thomson, K L Ayres, V Pilotti, et al.
Oncotarget|May 11, 2019
PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cellsFabiola Cervantes-Gomez, Christine M Stellrecht, Mary L Ayres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 25, 2015
Dose Optimization of the Administered Activity in Pediatric Bone Scintigraphy: Validation of the North American Consensus GuidelinesKaren L Ayres, Stephanie E Spottswood, Dominique Delbeke, et al.
Blood|May 6, 2010
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cellsKumudha Balakrishnan, Jan A Burger, Maite P Quiroga, et al.
Biochemical Pharmacology|May 30, 2009
Inhibition of ATP synthase by chlorinated adenosine analogueLisa S Chen, Billie J Nowak, Mary L Ayres, et al.
Frontiers in Oncology|May 25, 2023
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemiaNatalia Timofeeva, Mary L Ayres, Natalia Baran, et al.
Blood|April 22, 2014
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cellsAmal A El-Mabhouh, Mary L Ayres, Elizabeth J Shpall, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1985
[Immunologic parameters and HLA groups in 50 Portuguese families with insulin-dependent diabetes. Clinical and laboratory correlation]M Cruz, L G Correia, J Nunes Corrêa, et al.
Oncotarget|June 5, 2018
Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cellsHima V Vangapandu, Brandon Alston, Joshua Morse, et al.
Blood Cancer Journal|December 18, 2024
Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton's tyrosine kinase expression levelsGorkem Kismali, Ganiraju Manyam, Nitin Jain, et al.
Pageof 10